RECRUITING

IMPACT - AndHealth Autoimmune Research Registry

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a patient research registry aimed at evaluating the effectiveness of a comprehensive, root-cause medical approach ("AndHealth program") for autoimmune disorders. This approach involves a combination of pharmacological and non-pharmacological therapies offered under the care of a licensed physician with the support of health coaches. While protocol guidance is provided, the therapeutic approach is personalized to the individual needs of patients. The autoimmune disorders of focus in this registry include rheumatoid arthritis, psoriatic arthritis, psoriasis and ankylosing spondylitis. A variety of validated labs, patient-reported outcomes, and medication usage will be assessed among participating patients over a period of up to five years to evaluate the long-term effectiveness of this approach.

Official Title

Investigating Mechanisms of Participatory Autoimmune Condition Treatment (IMPACT): An Outcomes Research Registry of a Comprehensive Approach to Autoimmune Disorders

Quick Facts

Study Start:2023-06-08
Study Completion:2028-05-22
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05883371

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 70 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Adults 18 to 70 years of age
  2. 2. Able to understand and write English
  3. 3. Voluntarily consent to the study and understand its nature and purpose including potential risks and side effects
  4. 4. Documented diagnosis and current use/recommendation for biologic or DMARD medications to treat rheumatoid arthritis, psoriatic arthritis, psoriasis, or ankylosing spondylitis.
  1. 1. Pregnant, breastfeeding, or planning to become pregnant in the next 12 months
  2. 2. Advanced liver or kidney disease
  3. 3. Previous organ transplant or awaiting organ transplant
  4. 4. Actively being treated for cancer
  5. 5. Poorly-controlled mental illness (i.e., schizophrenia, bipolar, current eating disorder)
  6. 6. Has a terminal illness
  7. 7. Current opioid use

Contacts and Locations

Study Contact

Sonja Horner
CONTACT
614-697-3296
shorner@andhealth.com

Principal Investigator

Myles Spar, MD
PRINCIPAL_INVESTIGATOR
AndHealth

Study Locations (Sites)

AndHealth
Columbus, Ohio, 43215
United States

Collaborators and Investigators

Sponsor: AndHealth

  • Myles Spar, MD, PRINCIPAL_INVESTIGATOR, AndHealth

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-06-08
Study Completion Date2028-05-22

Study Record Updates

Study Start Date2023-06-08
Study Completion Date2028-05-22

Terms related to this study

Additional Relevant MeSH Terms

  • Arthritis, Rheumatoid
  • Arthritis, Psoriatic
  • Psoriasis
  • Ankylosing Spondylitis
  • Autoimmune Diseases